0% found this document useful (0 votes)
50 views25 pages

Novalife Healthcare Production Study

Uploaded by

kr600143
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
50 views25 pages

Novalife Healthcare Production Study

Uploaded by

kr600143
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 25

SRM VALLIAMMAI ENGINEERING

COLLEGE
(An Autonomous Institution)
Affiliated to Anna University, Chennai.

DEPARTMENT OF MANAGEMENT STUDIES

Topic: GENERAL STUDY ON PRODUCTION LEVEL


INTERNSHIP REPORT

Company Name: NOVALIFE HEALTHCARE


Address: NO.57,1ST FLOOR,5TH MAIN ROAD ,9TH
CROSS, CHAMARAJPET,BANGALORE-560018

Supervisor: MR. AKASH GADIYA- FOUNDTER

Prepared by: B. PADMAVATHY


Reg. No 142223631095
AY: 2024-25

Under the guidance of


DR. B. KIRUTHIGA
ASSISTANT PROFESSOR

Submitted to the Department of Management Studies


In partial fulfillment of the requirements for the award of the degree of
MASTER OF BUSINESS ADMINISTRATION

November, 2024
BONAFIDE CERTIFICATE

This is to certify that this internship report is the bonafide work of


Ms. PADMAVATHY.B (Reg. No.142223631095 )who carried out the study
under my supervision. Certified further, to the best of my knowledge, the work
reported herein does not form part of any other internship study report.

(DR. B.KIRUTHIGA) (Dr. Venkata SSR Muramalla)


Assistant professor, Head of the Department,
Department of Management Studies, Department of Management Studies,
SRM Valliammai Engineering College, SRM Valliammai Engineering College,
Kattankulathur. Kattankulathur.

2
DECLARATION

I, PADMAVATHY.B, REG. NO142223631095, student of the Department of

Management Studies, SRM Valliammai Engineering College, Kattankulathur,

declare that the internship report at “NOVALIFE HEALTHCARE” is submitted

in partial fulfillment of the Master’s Degree of Business Administration. This is

my original work and has not been submitted for the award of any degree,

diploma, fellowship, or other similar title or prizes.

Place: Signature of the Candidate

Date: PADMAVATHY.B

3
4
ACKNOWLEDGEMENT

I express my sincere thanks to our Director, Dr. B. Chidhambara Rajan,


M.E, Ph.D., and our Principal, Dr. M. Murugan, M.E, Ph.D., who permitted
me to do this internship and for providing all the facilities in the college
premises to prepare this report.

Next, I would like to record my heartfelt thanks to our Head of the Department,
Dr.Venkat SSR Muramalla, MBA, MPhil, PhD. for encouraging and
supporting me to undertake this internship.

I am grateful to my guide Dr. B. Kiruthiga, Assistant Professor whose timely


guidance and illuminating suggestions helped me complete my internship on
time. I also express my gratitude to the entire Department of Management
Studies staff for their guidance in the timely completion of this report.

It is an absolute profound sense of gratitude to express my heartfelt thanks to


my supervisor MR. AKASH GADIYA,FOUNDER for their timely guidance
& kind cooperation throughout the study. Their keen interest and encouraging
words at every step were a source of inspiration that enabled me to broaden my
sphere of domain knowledge. I would also like to thank all the employees of
NOVALIFE HEALTHCARE for their immense support and cooperation.

PADMAVATHY B

5
TABLE OF CONTENTS

CHAPTER TITLE PAGE NOs


(Min.25/Max.40).
I INTRODUCTION OF THE STUDY TOPIC 10

1.1 Importance of the topic.


1.2 Reasons for choosing the company/industry.
1.3 Objectives of the study.

II INDUSTRY PROFILE 12

2.1 Major Players in the Industry


III COMPANY PROFILE 19

3.1 Profile, Achievements/Milestones.


3.2 Organization Chart.
3.3 Overview of Functional Departments.
IV FINDINGS (OBSERVATIONS) 23

4.1 Study Observation


4.2 Study Findings

V SUMMARY & CONCLUSION 25

5.1 Summary
5.2 Conclusion

6
CHAPTER 1

1.INTORDUCTION OF THE STUDY

❖ Nova life Healthcare is counted amongst the prestigious and successful companies of
the industry due to the supervision and guidance of Mr. Jitesh Gadiya who is the reputed
Managing Director of the company.

❖ He is highly experienced and knowledgeable in his respective domain which helps him
to run the entire business systematically and smoothly with achieving the target goals
and objectives.

❖ Moreover, he motivates the entire workforce to work hard and complete the given task
on time with achieving the target objectives.

❖ Novalife Healthcare is an award-winning WHO-GMP quality certified, ISO 9001:2000


quality certified and FSSAI quality certified, pharma company established in the year
2009 at Bangalore, Karnataka, India.

❖ We have an array of products on wide ranging from Antibiotics, Antacids, Analgesics,


Anti-diabetic, Cough Suppressants to Nutritional supplements. All our products are
manufactured as per the industry standards and parameters.
Mission:
Nova Life Health Care is committed to delivering an exceptional patient care
experience that promotes healing and recovery in a compassionate environment.

Vision:
Their vision is to serve communities as the premier provider of adult rehabilitation
care, resulting in the highest level of independence for their patients1.

Values:
❖ Deliver superior quality care in all that they do.
❖ Treat others as they would like to be treated.
❖ Be results-oriented and achieve objectives.
❖ Be team players.
❖ Be resourceful in overcoming obstacles.

7
FUTURE GOALS
Nova Life Health Care’s future goals for 2025 likely align with broader trends in the
healthcare industry. Nova Life aims to continue its growth by nurturing opportunities,
applying innovative ideas for business improvement, and expanding its effective marketing
network to meet high performance standards.
• Technological Integration: Embrace advanced technologies like AI, machine
learning, and IoT to enhance predictive analytics and automate decision-making
processes.
• Quality and Compliance: Maintain rigorous quality control measures and adhere to
regulatory standards such as GMP to ensure product safety and efficacy.
• Sustainability: Implement sustainable practices, including reducing carbon footprint
and using renewable energy sources.
• Market Expansion: Expand distribution channels and strengthen market presence in
more cities and regions.

BRAND TRUST WORDS


Nova Life places high value on building strong relationships with
customers, ensuring their needs are met diligently. The company emphasizes the highest
standards of quality in all its products, from raw materials to finished goods, ensuring
consistency and safety. Nova Life is committed to ethical business practices, integrity, and
honesty, aiming for customer satisfaction and mutual growth. The company focuses on
applying creative ideas for business improvement and nurturing growth opportunities.

IMPORTANCE OF THE STUDY


Studying organization production planning and controlling in pharmaceutical companies,
is important because it help to understand how to create a success in the organization and to
achieve the desire goals.
• Emphasizes the importance of strategic, tactical, and operational planning in
achieving organizational goals. It includes setting timelines, risk assessment, and
monitoring progress.
• Focuses on demand forecasting, production scheduling, resource management, and
quality control to ensure efficient manufacturing processes.
• Addresses regulatory compliance, quality assurance, supply chain management, and

8
inventory management. It suggests strategies like advanced analytics, lean
manufacturing, and robust quality management systems to overcome these challenges.
• Highlights the role of technology in enhancing pharmacy operations, including the use
of Pharmacy Management Systems (PMS), Electronic Health Records (EHR), and
automated dispensing systems to improve efficiency and accuracy.
• Aims to continue its growth by nurturing opportunities, applying innovative ideas for
business improvement, and expanding its effective marketing network to meet high
performance standards.

REASON FOR CHOOSING THE COMPANY


I chose Nova Life Care due to its well-established reputation in the
pharmaceutical industry and its focus on operational excellence. The company's operations
department provides exposure to critical aspects of pharmaceutical operations, including
supply chain management, quality control, inventory management, and regulatory
compliance. This experience will allow me to gain a well-rounded understanding of the
operational processes that are essential for ensuring product quality and timely delivery in the
healthcare sector.
My primary reason for selecting Nova Life Care is my strong interest in
operations, especially in learning how efficient operational practices contribute to both
patient satisfaction and organizational success. I view this role as an opportunity to gain
hands-on experience in areas that I have not yet explored, which will significantly enhance
my practical knowledge.
Additionally, Nova Life Care is known for its commitment to innovation
and continuous improvement in its operational processes. Working in such a dynamic
environment will enable me to learn from industry experts, gain insights into best practices in
pharmaceutical operations, and deepen my understanding of the complexities involved in this
field. I believe this experience will equip me with the skills necessary to excel in the
operations sector.

OBJECTIVE OF THE STUDY:


1. To Analyse Operational Efficiency: Evaluate the efficiency of current operational
processes, including production, quality control, and supply chain management, to identify
areas for improvement and reduce costs.
2. To Assess Quality Control Mechanisms: Examine the effectiveness of quality control

9
systems in place to ensure that products meet regulatory standards and are safe for
consumption.
3. To Study Inventory Management Practices: Investigate the company’s inventory
management practices to optimize stock levels, reduce waste, and prevent shortages in the
supply chain.
4. To Explore Regulatory Compliance: Understand how the operations department ensures
compliance with industry regulations and standards, identifying potential areas for risk
mitigation.
5. To Enhance Process Innovation: Identify opportunities for process innovation within the
operations department to streamline production cycles and increase overall productivity.
6. To Examine Supply Chain Resilience: Assess the resilience of the supply chain to handle
disruptions, such as raw material shortages, to improve the company’s adaptability and
responsiveness.
7. To Improve Customer Satisfaction: Explore the relationship between operational efficiency
and customer satisfaction by ensuring timely and quality product delivery.
8. To Foster Sustainability: Investigate sustainable practices within operations, such as
reducing waste and energy use, to align with environmental goals and reduce the company’s
carbon footprint.

10
CHAPTER 2
INDUSTRIAL PROFILE

The pharmaceutical industry involves the research, development, production, and distribution
of drugs and therapies aimed at treating diseases and improving health.
It is one of the most regulated sectors globally due to its impact on public health and safety.
Companies in this industry range from large, multinational corporations (like Pfizer, Merck,
and Novartis) to small, specialized biotech firms.
Key Segments
o Branded Drugs: High-revenue segment dominated by patented drugs, developed
through rigorous R&D.
o Generic Drugs: Off-patent drugs that provide more affordable alternatives and drive
competition.
o Biologics and Biosimilars: Complex, protein-based drugs often derived from living
organisms, with biosimilars emerging as competitive options post-patent expiration.
o Over-the-Counter (OTC) Medicines: Non-prescription drugs that provide revenue
diversification.
Research and Development (R&D)
• R&D is critical, with companies investing heavily to innovate new treatments. It
includes preclinical research, clinical trials, and regulatory approval.
• Clinical trials are lengthy and costly, and only a small percentage of drugs in
development make it to market.
• Companies often collaborate with research institutions, universities, or other firms to
share costs and expertise.

Market Drivers
o Aging Population: Increases in chronic diseases like diabetes, cancer, and

cardiovascular conditions fuel demand for medications.


o Advancements in Biotechnology: Genomics and personalized medicine drive new
treatments tailored to specific patient profiles.
o Rising Healthcare Spending: As healthcare systems worldwide expand, the
pharmaceutical sector benefits from higher spending and insurance coverage.
Key Challenges
o Regulatory Compliance: Strict regulations by authorities like the FDA and EMA

11
affect timelines and costs, especially for new drugs.
o Intellectual Property (IP) and Patent Expirations: Loss of patent protection can lead to
generic competition, impacting revenue.
o High R&D Costs and Failure Rates: Many drugs fail in trials, making drug
development expensive and risky.
o Pricing Pressures: Rising scrutiny from governments and consumers on drug pricing
affects profitability, particularly in the U.S. market.
Trends and Innovations
o Focus on Rare Diseases: Orphan drugs for rare diseases provide high returns due to
Digital Health and AI: AI is used in drug discovery, data analysis, and personalized
medicine to streamline R&D.
o Mergers and Acquisitions (M&A): Companies pursue M&As to expand their product
portfolios, enter new markets, and leverage specialized demand and regulatory
incentives.
o Shift Towards Value-Based Care: Pressure is increasing for drugs to demonstrate
efficacy and cost-effectiveness in real-world scenarios.
Global Market Outlook
o The pharmaceutical market is expected to grow, driven by emerging markets, the
demand for innovative treatments, and advancements in healthcare
o Developing regions like Asia-Pacific and Latin America offer new opportunities due
to improving healthcare infrastructure and growing economies.
Major Players
o Key players include large multinational corporations (e.g., Johnson & Johnson,
Roche, Sanofi), which lead in sales, R&D, and market influence.
o Small biotech firms also play an essential role in innovation, often targeting specific
niches or developing initial-stage treatments that larger companies may acquire.
Future Outlook
o Growth is expected in areas like oncology, immunology, and neuroscience due to
unmet needs.
o Increasing competition from biosimilars and generics will pressure profit margins.
o The role of technology in drug discovery and delivery is expected to continue
evolving, potentially reducing development timelines.
o The pharmaceutical industry is both highly profitable and highly volatile, with
immense investment in R&D offset by regulatory risks and public scrutiny

12
CHAPTER 3
COMPANY PROFILE

INTRODUCTION
At Novalife, we always believe that great businesses are the results of great
partnerships. For the same reason, we place high value in every customer and his needs and
work endlessly upon building a good rapport with each one of them. Perhaps, this paradigm
of placing our customers first has enabled us to penetrate the domestic market successfully in
a very short span of time. Sharing strong bond with the customers, attending to their needs
diligently and healthy mutual growth leading is what we strive to achieve at Nova life
Nova life Healthcare is counted amongst the prestigious and successful
companies of the industry due to the supervision and guidance of Mr. Jitesh Gadiya who is
the reputed Managing Director of the company. He is highly experienced and knowledgeable
in his respective domain which helps him to run the entire business systematically and
smoothly with achieving the target goals and objectives. Moreover, he motivates the entire
workforce to work hard and complete the given task on time with achieving the target
objectives.
Quality is the hallmark of Nova life. Finest quality has known to be synonymous
with our products. Right from the inception stages, quality has found a profound place in all
our endeavours.
At every phase of manufacturing, right from raw materials to finished products,
highest standard of quality is ensured with the help of most modern equipment, trained
personnel and state-of-the-art manufacturing facilities. All production facilities match highest
standards of hygiene and with all equipment’s undergoing periodic inspection from time to
time for consistency from batch to batch, the odds of defects are literally zeroed down. Our
manufacturing facilities are certified by WHO GMP certified. At Nova life, we live by the
highest standards of ethics and have a steadfast commitment to customer satisfaction.
We are an award winning, fast growing and quality certified pharma company
based in Bangalore. We are committed to reform healthcare in India and are flagbearers of
ethical business practices.

Highest standards of ethics


o Integrity and honesty
o Gain deep understanding of our customers and domains
o Steadfast commitment to customer satisfaction
o Apply creative and breakthrough ideas for business improvement

o Nurture growth opportunities to enable growth with the passage of every single day
o Build an effective marketing network to serve the needs of a medical profession
o ISet and meet high standards of performance

13
Key Features of a Reliable Pharma Franchise
o Certifications, Accreditations and Licenses: WHO-GMP, ISO 1:2015 and FSSAI
quality certified. Quality is the hallmark of Nova life. • Product Range: Widest range
of 350+ products. One-stop solution for all your product needs
o Monopoly: We provide monopoly based exclusive rights to our partners for marketing
your own products manufactured by us
o Promotional Material: We provide Visual-aids, MR bags, Literatures, LBL’s and
other marketing support to help you achieve your desired sales targets

o Manufacturing Plant: Own manufacturing unit. If you choose us, you're getting
productsat better margins and max savings, direct-from-manufacturer
o Regulatory Authority Approvals: All products DCGI/DPCO approved
o Packaging: No damages to packaging during transit time. We provide leakage proof
and damage resistance packaging & delivery
o Timely Delivery: We are a commitment-based firm run by professional leaders &
managers. All products dispatched from us are delivered within committed timelines
o Market Knowledge: Well, experienced in Market Knowledge & Intelligence.
o Sales Network: Distribution channels in 40+ cities
o Pricing & Marketing: All products are priced under NPP Policy 2012 & marketed
under CAPMM Policy of Department of Pharmaceuticals, Govt of India
o Savings: Maximum savings guaranteed on bulk orders.

PRODUCT LIST
o Inflammatory, Analgesics & Anti-spasmodic
o Antacid, Anti-flatulent, Anti-emetic & Anti-ulcer ant
o Anti-biotic ▪ Anti-cold, Anti-allergic & Cough Suppressants
o Gynae & Infertility Range
o Orthopaedic Range
o Vitamins, Minerals, Proteins & Other Nutritional Supplements

14
o Derma
o Pre-Probiotics
o Steroids
o Dental Range
o Anti-diabetic
o We have an array of products on offer ranging from Antibiotics, Antacids,
Analgesics, Anti-diabetic, Cough Suppressants to Nutritional supplements. Reminder
Card is supposedly the best way to increase your chances for brand promotion
through doctors

INFLAMATORY, ANALGESICS & ANTI-SPASMODIC


o Aceclofenac 200mg S.R
o . Aceclofenac 100mg + Paracetamol 325mg
o Aceclofenac 100mg + Diacerein 50mg
o Aceclofenac 100mg + Paracetamol 325mg + Thiocolchicoside 4mg
o Diclofenac Sodium 75mg (AQUA BASE)
o Diclofenac Sod. 50mg + Paracetamol 325mg + Serratiopept
o Etoricoxib 90mg
o Etoricoxib 60mg + Thiocolchicoside 4mg
o Nimesulide 100mg + Paracetamol 325mg
o Thiocolchicoside 4mg
oTrypsin-Chymotrypsin 100000 a.u Tablet
ANTACID, ANTI-FLATULENT, ANTI-EMITIC & ANTI-ULCERANT
o Ondansetron 4mg
o Rabeprazole Sodium 20mg
o Esomeprazole 40mg
o Cefixime 100 mg DT 7
o Linezolid 600 mg
o Meropenam 1gm
o Acebrophylline 100 mg
o Rifaximin Tablets 200mg
o Clindamycin 300mg Capsules
o Esomeprazole 40mg + Levosulpiride 75mg
ANTI-BIOTIC
o Ceftriaxone 1000 mg
o Ceftriaxone 1000mg + Sulbactam 500mg
o Cefoperzone 500mg + Sulbactam 500mg
o Cefixime 100 mg DT
o Cefuroxime Axetil 250mg
o Cefuroxime Axetil 500mg Tabs
o Cefpodoxime Proxetil 100mg DT
o Cefpodoxime Proxetil-200mg DT
o Cefpodoxime Proxetil 50mg Dry Syrup

15
o Azithromycin 250mg
ANTI-COLD, ANTI-ALLERGIC & COUGH SUPPRESSANTS
o Paracetamol 650mg
o Paracetamol 250mg Suspension
o Paracetamol Infusion IP 1.0%w/v
o Levocetirizine Hydrochloride tablets o Bilastine & Montelukast Tablets
o Montelukast 10mg + Doxophylline 400mg
o Montelukast 10mg + Levocetirizine 5mg
o Montelukast 4mg + Levocetirizine 2.5mg
o Dydrogesterone tablets 10mg
ORTHOPEDIC RANGE
o Coral Calcium & Vitamin D3 tablet
o Polmacoxib 2mg Capsules
o Diacerin 50mg + Glucosamine Sulphate 750mg + M.S.M.250mg Tabs
o Mecobalamin 750 mcg+ Glucosamine 500mg +M.S.M.250. Tabs
o Calcium Citrate 1000 mg
EYE EAR RANGE
o Carboxymethylcellulose 0.5 w/w
o Moxifloxacin Opthalmic Suspension 0.5% w/v
o Ofloxacin 0.3% Eye Drops
GYNAE & INFRTILITY RANGE
o Dydrogesterone tablets 10mg
o Dydrogal 20 Dydrogesterone tablets 10mg
o Yufit D3 Drops Dydrogesterone tablets 10mg
VITAMINS, MINERALS,PROTEINS & OTHER NUTRITIONAL
SUPPLEMENTS
o Protein powder fortified with DHA
o Digestive enzyme with B-Complex Syrup
o Liver Tonic With Double Strength
o Immunity powder Energy Drink

16
OVERVIEW FUNCTIONAL DEPARTMENT

Human Resources (HR)


Manages recruitment, employee relations, training, development, payroll,
benefits, and compliance. To support the organization by hiring the right talent, fostering a
positive work environment, and ensuring employees are adequately compensated and
motivated

Finance and Accounting


Handles budgeting, financial planning, accounting, audits, tax planning, and
investment To manage financial resources, ensure financial health, and provide financial
insights that inform strategic decision-making
.

17
Marketing
Focuses on branding, advertising, market research, public relations, and customer
engagement. To create brand awareness, drive customer demand, and generate leads to
support sales and growth

Sales
Engages with customers, manages accounts, negotiates deals, and closes sales. To
increase revenue, expand market reach, and establish strong customer relationships to ensure
business growth.

Operations
Manages production, logistics, supply chain, quality control, and inventory. To ensure
products or services are delivered efficiently and meet quality standards, optimizing cost and
time.

IT (Information Technology)
Manages technology infrastructure, cybersecurity, software development, and digital
transformation. To support organizational technology needs, enhance productivity through
digital tools, and safeguard data and systems.

Research and Development (R&D)


Innovates and develops new products, improves existing products, and conducts
market and technical research. To keep the company competitive by fostering innovation and
ensuring product relevance in the market.

Customer Service
Addresses customer inquiries, resolves issues, and provides support for products and
services. To improve customer satisfaction, retain customers, and build brand loyalty through
positive interactions.

Legal
Handles contracts, compliance, intellectual property, and litigation. To protect the
organization legally, ensure regulatory compliance, and mitigate risks.

Strategic Planning or Corporate Development


Focuses on long-term goals, partnerships, mergers, acquisitions, and strategic
initiatives. To guide the organization’s growth, explore new opportunities, and align
resources with the company’s vision.

18
ORGANIZATION CHART

19
CHAPTER IV

STUDY OBSERVATION

4.1 STUDY OBSERVATION

Novalife Healthcare may use observational studies, which are crucial in real-
world healthcare research for studying patient outcomes, treatment effectiveness, and disease
progression in natural clinical settings. These studies differ from clinical trials as they do not
involve intervention from researchers, making them ideal for gathering evidence on long-
term safety, treatment patterns, and patient behavior
There are various observational study types: cohort studies, which follow a
group over time; case-control studies, which compare patients with a condition to those
without; and cross-sectional studies, which examine a population at a single point in time.
Additionally, longitudinal studies track changes over a longer duration, and ecological studies
analyze population-level data. Observational research often faces challenges such as selection
bias, missing data, and confounding variables, which can make it difficult to determine
causality. However, methods like propensity score matching and instrumental variable
analysis help mitigate these biases to improve study reliability.
Furthermore, the integration of big data and machine learning (ML) is
transforming observational studies by enabling advanced analyses across large and varied
datasets, such as electronic health records, patient registries, and social media. ML
applications can help predict disease progression, identify subpopulations within data, and
generate real-world evidence for healthcare providers and policymakers, potentially
enhancing clinical guidelines and health policies in practical, data-driven ways.

Workflow Efficiency and Interruptions


Observing workflow interruptions, such as those caused by
communication breakdowns or equipment malfunctions, can highlight potential areas for
improvement. Studies indicate that minimizing these interruptions can significantly improve
operational efficiency and staff productivity, especially in busy healthcare environments

Task Load and Employee Workload


Monitoring workload levels and task demands, potentially through tools like
the NASA Task Load Index, can help understand the mental and physical demands placed on
staff. This can be essential in ensuring that workload levels are manageable and do not
contribute to burnout, which in turn can impact quality of care and operational effectiveness.

Safety and Risk Management


Observational studies in healthcare often reveal latent safety risks that are
difficult to detect retrospectively. Observers can note near-miss incidents or workarounds that

20
staff might employ to cope with limitations in resources or processes, providing critical
insights for risk management.

Process Optimization
Through structured observations, inefficiencies in patient and equipment
flow can be identified. Tracking movements and bottlenecks in real-time allows for
adjustments in layout or process design that can speed up response times and improve patient
throughput, especially in high-demand areas like the emergency or operating rooms

Staff Interaction and Communication


Interactions between staff members, including how and when they
communicate, can affect both efficiency and safety. Observing these patterns can help to
identify communication barriers and improve team dynamics, which are crucial for smooth
operation in complex environments like healthcare.

Patient Flow and Throughput:


Observing the time and steps taken from patient admission to discharge or transfer
can reveal bottlenecks in care delivery. This includes monitoring wait times, patient transfers
between departments, and any delays in treatment. Optimizing patient flow can reduce
congestion in high-demand areas and improve overall care quality.

Resource Utilization and Allocation


Observing the usage patterns of resources, such as equipment, operating rooms,
and beds, can help identify underused or overburdened resources. Data on equipment
downtime, availability, and maintenance needs can guide decisions about resource allocation
and capital investments.

Task Coordination and Role Clarity


In high-stakes healthcare settings, clear task assignments and role definitions are
essential. Observing team interactions and role clarity, especially during shift changes, can
highlight any miscommunications or role overlaps that might slow down operations or lead to
errors. Ensuring clear delegation can improve team efficiency and patient outcomes

Standard Operating Procedure (SOP) Adherence


Observing how closely staff adhere to SOPs can identify gaps between standard
practices and real-world application. Non-adherence to procedures can point to practical
issues, such as insufficient training or unrealistic protocols, and may indicate areas where
SOPs need updating or more flexibility.

Technology Integration and Usage Patterns


Monitoring how technology (such as electronic health records, patient monitoring
systems, and diagnostic tools) is integrated into daily operations can reveal usability issues or

21
training gaps. Ensuring that staff are proficient in the technology they use daily is essential
for both efficiency and patient safety.

Patient and Staff Satisfaction


Observing not only the workflow but also conducting periodic satisfaction surveys
with patients and staff can provide a fuller picture. Patient feedback on care and staff
feedback on working conditions and workload can highlight areas for improvement and can
be used to prioritize operational changes.

Environmental Factors
Observational studies can also consider factors like noise levels, lighting, and
spatial arrangement, which can impact staff performance and patient comfort. Environmental
factors play a role in both patient satisfaction and the efficiency with which healthcare staff
can perform their duties.

4.2 STUDY FINDINGS

Efficiency and Productivity


Cycle Time Analysis: Many studies find that production processes can often be
streamlined, reducing cycle times and increasing throughput.
Bottlenecks: Identifying and addressing bottlenecks in the production line can
significantly improve overall efficiency.

Quality Control
Defect Rates: Research often highlights the correlation between effective quality
control measures and reduced defect rates, leading to lower costs and improved customer
satisfaction. Root Cause Analysis: Findings frequently indicate that implementing root cause
analysis techniques can help in addressing recurring quality issues.

Lean Manufacturing Practices


Waste Reduction: Many studies emphasize the importance of lean practices in
minimizing waste, which can lead to substantial cost savings. Kaizen Events: Continuous
improvement initiatives, like Kaizen, can yield significant productivity gains and employee
engagement.

Technology and Automation


Impact of Automation: Findings typically demonstrate that introducing
automation can enhance production speed and accuracy, though it may require initial capital
investment. Data Analytics: Utilizing data analytics for predictive maintenance can reduce

22
downtime and maintenance costs.

Employee Engagement and Training


Skill Development: Studies often find that regular training programs improve
employee skills and contribute to better overall performance.
Motivation and Morale: Higher employee engagement is linked to improved
productivity and lower turnover rates.

Supply Chain Management


Inventory Management: Research frequently shows that effective inventory
management techniques can lead to lower holding costs and improved cash flow.
Supplier Relationships: Strong relationships with suppliers can enhance supply
chain efficiency and product quality.

Environmental Impact
Sustainability Practices: Findings often indicate that sustainable practices can lead
to cost savings and a better corporate image, attracting environmentally-conscious
consumers.

Health and Safety


Incident Rates: Studies reveal that implementing comprehensive safety training and
protocols can reduce workplace incidents and associated costs.

23
CHAPTER V

5.1. SUMMARY

The production department at Nova Life Healthcare has conducted a comprehensive study to
identify key areas for improvement and enhance overall efficiency. One of the primary
findings from this study is the importance of monitoring patient flow from admission to
discharge. By identifying bottlenecks in the care delivery process, the department can
implement strategies to optimize patient flow, reduce congestion, and ensure that patients
receive timely and effective care. This not only improves operational efficiency but also
enhances patient satisfaction and outcomes.
Resource utilization is another critical area highlighted by the study. By analyzing the usage
of equipment and beds, the department discovered instances of both underutilization and
overburden. This insight is crucial for making informed decisions about resource allocation
and investments. For example, underutilized equipment can be repurposed or relocated to
areas with higher demand, while overburdened resources may require additional support or
upgrades. Effective resource management ensures that the department operates smoothly and
can meet the needs of patients without unnecessary delays or shortages.
Task coordination within the production department has also been a focus of the study. Clear
task assignments and well-defined roles are essential for improving team efficiency and
patient outcomes. The study found that reducing miscommunications and role overlaps leads
to smoother operations and better collaboration among staff members. This, in turn, enhances
the overall quality of care provided to patients. By ensuring that each team member
understands their responsibilities and has the necessary support, the department can function
more effectively and deliver higher standards of care.
Technology integration plays a significant role in the operations of the production
department. The study emphasized the need to monitor the use of technology to identify
usability issues and training gaps. Ensuring that staff are proficient in using technological
tools is vital for improving efficiency and patient safety. For instance, automated systems for
medication dispensing or electronic health records can streamline processes and reduce the
risk of errors. However, these benefits can only be realized if staff are adequately trained and
comfortable using the technology. Addressing any gaps in training and usability can lead to
more efficient operations and better patient care.
In summary, the study conducted by the production department at Nova Life Healthcare
underscores the importance of effective production planning and control. By focusing on
patient flow, resource utilization, task coordination, and technology integration, the
department can enhance operational efficiency and maintain high standards of patient care.
These findings provide a roadmap for continuous improvement and ensure that Nova Life
Healthcare remains a leader in the healthcare industry.

24
5.2 CONCLUTION

The internship at Nova Life Healthcare’s production department provided invaluable insights
into the operational aspects of a leading pharmaceutical company. Throughout the internship,
several key areas were explored, leading to significant findings and recommendations for
future improvements. One of the primary focuses was on optimizing patient flow from
admission to discharge. By identifying and addressing bottlenecks in the care delivery
process, the department can enhance operational efficiency and ensure timely patient care.
This not only improves patient satisfaction but also contributes to better health outcomes.
The internship provided a comprehensive understanding of the production department’s
operations at Nova Life Healthcare. The findings underscore the importance of effective
production planning and control in maintaining high-quality patient care and operational
efficiency. The recommendations made during the internship can serve as a roadmap for
continuous improvement, ensuring that Nova Life Healthcare remains at the forefront of the
healthcare industry.
In conclusion, the internship experience was highly educational and provided practical
insights into the complexities of healthcare operations. The knowledge gained and the
recommendations made will contribute to the ongoing efforts to enhance the efficiency and
effectiveness of the production department at Nova Life Healthcare.

25

You might also like